IAIM
TGTX icon

International Assets Investment Management’s TG Therapeutics TGTX Stock Holding History

International Assets Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13
Closed -$196 – 989
2023
Q1 		$196 Buy
+13
New +$197 ﹤0.01% 1108

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

International Assets Investment Management's TGTX Position: Q2 2023 in Review

International Assets Investment Management sold out of TG Therapeutics (TGTX) in Q2 2023, closing a stake of 13 shares — an estimated $196 sold.

International Assets Investment Management first reported a position in TGTX in Q1 2023 and held it in 1 quarter. The position peaked at $196 in Q1 2023. 244 funds tracked by Wall St. Rank hold TGTX as of Q2 2023.

  • International Assets Investment Management reported no remaining TG Therapeutics position as of Q2 2023 after selling out during the quarter.
  • International Assets Investment Management sold 13 TG Therapeutics shares in Q2 2023, an estimated $196.
  • International Assets Investment Management first reported a position in TG Therapeutics in Q1 2023 and held it in 1 quarter.
  • International Assets Investment Management's TG Therapeutics position peaked at $196 in Q1 2023.
  • 244 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2023.

Based on International Assets Investment Management's 13F filing for Q2 2023, filed 20 Jul 2023.